chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection
Clinical narrative: herpes outbreak; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES VIRUS INFECTION (herpes outbreak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES VIRUS INFECTION (herpes outbreak). At the time of the report, HERPES VIRUS INFECTION (herpes outbreak) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. Treatment medications were not reported   Reporter did not allow further contact
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Administration site irritation, Vaccination site erythema, Vaccination site infection, Vaccination site inflammation, Vaccination site pain
Clinical narrative: infection on the injection site; redness on the injection site; sometimes painful; inflamed; annoying; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFECTION (infection on the injection site), VACCINATION SITE ERYTHEMA (redness on the injection site), VACCINATION SITE PAIN (sometimes painful), VACCINATION SITE INFLAMMATION (inflamed) and ADMINISTRATION SITE IRRITATION (annoying) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure and Gout.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFECTION (infection on the injection site), VACCINATION SITE ERYTHEMA (redness on the injection site), VACCINATION SITE PAIN (sometimes painful), VACCINATION SITE INFLAMMATION (inflamed) and ADMINISTRATION SITE IRRITATION (annoying). At the time of the report, VACCINATION SITE INFECTION (infection on the injection site), VACCINATION SITE ERYTHEMA (redness on the injection site), VACCINATION SITE PAIN (sometimes painful), VACCINATION SITE INFLAMMATION (inflamed) and ADMINISTRATION SITE IRRITATION (annoying) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extreme fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced FATIGUE (extreme fatigue). At the time of the report, FATIGUE (extreme fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-083137 (Patient Link).
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Inappropriate schedule of product administration, Off label use
Clinical narrative: chills; Second dose received on day 96; scheduled for third dose; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), OFF LABEL USE (Second dose received on day 96) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for third dose) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 011J20A.) for COVID-19 vaccination.     Concomitant products included METOPROLOL SUCCINATE (TOPROL XL), ALPRAZOLAM (AZOR [ALPRAZOLAM]), ATORVASTATIN CALCIUM (LIPITOR), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), LORAZEPAM (ATIVAN), ALLOPURINOL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication, MULTIVITAMIN & MINERAL.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced CHILLS (chills), OFF LABEL USE (Second dose received on day 96) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for third dose). On 13-Apr-2021, CHILLS (chills), OFF LABEL USE (Second dose received on day 96) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for third dose) had resolved.            No laboratory data was provided.   No treatment information was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-083078, US-MODERNATX, INC.-MOD-2021-083133, US-MODERNATX, INC.-MOD-2021-083104 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Follow-up received on 03-May-2021 contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083078:Husband's first dose US-MODERNATX, INC.-MOD-2021-083104:Wife's 1st dose US-MODERNATX, INC.-MOD-2021-083133:Wife's 2nd dose
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lethargy, Tinnitus, Vaccination site pain
Clinical narrative: Both arm sores from this morning; From last evening and night she had ringing ears in both ears; Very lethargic; Still very drained; Having a constant headache; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Very lethargic), TINNITUS (From last evening and night she had ringing ears in both ears), VACCINATION SITE PAIN (Both arm sores from this morning), FATIGUE (Still very drained) and HEADACHE (Having a constant headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced LETHARGY (Very lethargic), FATIGUE (Still very drained) and HEADACHE (Having a constant headache). On 20-Apr-2021, the patient experienced TINNITUS (From last evening and night she had ringing ears in both ears). On 21-Apr-2021, the patient experienced VACCINATION SITE PAIN (Both arm sores from this morning). At the time of the report, LETHARGY (Very lethargic) and VACCINATION SITE PAIN (Both arm sores from this morning) outcome was unknown, TINNITUS (From last evening and night she had ringing ears in both ears) had resolved and FATIGUE (Still very drained) and HEADACHE (Having a constant headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported.  No treatment medication was provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Mass
Clinical narrative: Lump on right hand is the size of a small egg; LUMP ON BOTH HANDS; This spontaneous case was reported by a consumer and describes the occurrence of MASS (LUMP ON BOTH HANDS) and MASS (Lump on right hand is the size of a small egg) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MASS (LUMP ON BOTH HANDS). On 23-Mar-2021, the patient experienced MASS (Lump on right hand is the size of a small egg). At the time of the report, MASS (LUMP ON BOTH HANDS) and MASS (Lump on right hand is the size of a small egg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not included. Treatments included ice packs to short-term antibiotics.   This case was linked to US-MODERNATX, INC.-MOD-2021-083074 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083074:case for first dose
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pain in extremity, Vaccination site movement impairment
Clinical narrative: feeling sick; cannot lift left arm; arm  soreness; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling sick), VACCINATION SITE MOVEMENT IMPAIRMENT (cannot lift left arm), PAIN IN EXTREMITY (arm  soreness) and FATIGUE (fatigue) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced MALAISE (feeling sick), VACCINATION SITE MOVEMENT IMPAIRMENT (cannot lift left arm), PAIN IN EXTREMITY (arm  soreness) and FATIGUE (fatigue). At the time of the report, MALAISE (feeling sick), VACCINATION SITE MOVEMENT IMPAIRMENT (cannot lift left arm), PAIN IN EXTREMITY (arm  soreness) and FATIGUE (fatigue) had resolved. Not Provided          No concomitant medication was reported. Treatment medication were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: TCR added on 20-May-2021: Additional event added; Sender's Comments:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Seasonal allergy
Clinical narrative: lip swelling; Earlier Seasonal Allergy Response; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lip swelling) and SEASONAL ALLERGY (Earlier Seasonal Allergy Response) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028AZ1A) for COVID-19 vaccination.     The patient's past medical history included post traumatic. Concurrent medical conditions included Seasonal allergy.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced LIP SWELLING (lip swelling) and SEASONAL ALLERGY (Earlier Seasonal Allergy Response). At the time of the report, LIP SWELLING (lip swelling) and SEASONAL ALLERGY (Earlier Seasonal Allergy Response) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported  The patient generally treats seasonal allergy with a 'double' dose of Allegra.  The patient said that her next shot is due on 26APR2021.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Inappropriate schedule of product administration, Myalgia, Off label use
Clinical narrative: body aches; chills; lowfever; Headache; second dose received on day 96; scheduled for their third dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever), HEADACHE (Headache) and OFF LABEL USE (second dose received on day 96) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not provided.  Concomitant products included METOPROLOL SUCCINATE (TOPROL XL), AMLODIPINE BESILATE (NORVASC), PROGESTERONE, CLONAZEPAM, FAMOTIDINE, ACETYLSALICYLIC ACID (ASPIRINE) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever), HEADACHE (Headache) and OFF LABEL USE (second dose received on day 96). 13-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for their third dose). On 15-Apr-2021, MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever) and HEADACHE (Headache) had resolved. At the time of the report, OFF LABEL USE (second dose received on day 96) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for their third dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.         On 9-Jan-2021, patient went to the hospital and received an antibody infusion, BAMLAN monoclonal antibodies and came home the same day after the treatment. She was instructed to wait 90days and start the vaccination series all over again. She received her second dose on 13April 2021. The third dose is scheduled for 11-May-2021.   This case was linked to MOD-2021-083078, MOD-2021-083092 (E2B Linked Report). This case was linked to MOD-2021-083133 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Received TCR for. No new information provided.; Sender's Comments:  MOD-2021-083078:Husband's first dose MOD-2021-083092:Husband's second dose
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: body aches; chills; lowfever; Headache; second dose received on day 96; scheduled for their third dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever), HEADACHE (Headache) and OFF LABEL USE (second dose received on day 96) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not provided.  Concomitant products included METOPROLOL SUCCINATE (TOPROL XL), AMLODIPINE BESILATE (NORVASC), PROGESTERONE, CLONAZEPAM, FAMOTIDINE, ACETYLSALICYLIC ACID (ASPIRINE) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever), HEADACHE (Headache) and OFF LABEL USE (second dose received on day 96). 13-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for their third dose). On 15-Apr-2021, MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever) and HEADACHE (Headache) had resolved. At the time of the report, OFF LABEL USE (second dose received on day 96) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for their third dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.         On 9-Jan-2021, patient went to the hospital and received an antibody infusion, BAMLAN monoclonal antibodies and came home the same day after the treatment. She was instructed to wait 90days and start the vaccination series all over again. She received her second dose on 13April 2021. The third dose is scheduled for 11-May-2021.   This case was linked to MOD-2021-083078, MOD-2021-083092 (E2B Linked Report). This case was linked to MOD-2021-083133 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Received TCR for. No new information provided.; Sender's Comments:  MOD-2021-083078:Husband's first dose MOD-2021-083092:Husband's second dose
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment drugs were reported.   This case was linked to MOD21-079602, MOD21-079690, US-MODERNATX, INC.-MOD-2021-083535, US-MODERNATX, INC.-MOD-2021-083652 (E2B Linked Report).; Sender's Comments:  MOD21-079602: MOD21-079690: US-MODERNATX, INC.-MOD-2021-083535: US-MODERNATX, INC.-MOD-2021-083652:Brother case
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: still feeling a little bit of symptoms from corona; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (still feeling a little bit of symptoms from corona) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (still feeling a little bit of symptoms from corona). The patient was treated with PARACETAMOL (TYLENOL) for Sinus headache, at a dose of 1 dosage form. At the time of the report, COVID-19 (still feeling a little bit of symptoms from corona) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, SARS-CoV-2 test: positive (abnormal) covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant  medications included reflux pill everyday  Treatment details included Tylenol sinus and headache
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: Diagnosed with arthritis; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Diagnosed with arthritis) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine allergy), Drug allergy (Aspirin Allergy) and Penicillin allergy.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced ARTHRITIS (Diagnosed with arthritis). At the time of the report, ARTHRITIS (Diagnosed with arthritis) outcome was unknown.            .
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat; Slight Fever; Swollen Lymph nodes on the neck; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Slight Fever) and LYMPHADENOPATHY (Swollen Lymph nodes on the neck) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Slight Fever) and LYMPHADENOPATHY (Swollen Lymph nodes on the neck). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Slight Fever) and LYMPHADENOPATHY (Swollen Lymph nodes on the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided.
Age: 65.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: left arm sore; chills; body aches/ pain; Headache; low grade temp; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (left arm sore), CHILLS (chills), MYALGIA (body aches/ pain), HEADACHE (Headache) and PYREXIA (low grade temp) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (left arm sore), CHILLS (chills), MYALGIA (body aches/ pain), HEADACHE (Headache) and PYREXIA (low grade temp). At the time of the report, PAIN IN EXTREMITY (left arm sore), CHILLS (chills), MYALGIA (body aches/ pain), HEADACHE (Headache) and PYREXIA (low grade temp) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication use was not provided by the reporter  Treatment no meds at this time patient reports he may take an ibuprofen.   Reporter did not allow further contact
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Glossodynia, Headache, Influenza like illness, Myalgia
Clinical narrative: flu like symptoms; Arm started to ache; tongue felt weird; tongue was stinging; achiness; tiredness; Whole body started to ache; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (Arm started to ache), PARAESTHESIA ORAL (tongue felt weird), GLOSSODYNIA (tongue was stinging) and MYALGIA (achiness) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] and CALCIUM for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (Arm started to ache), PARAESTHESIA ORAL (tongue felt weird), GLOSSODYNIA (tongue was stinging), MYALGIA (achiness), FATIGUE (tiredness), VACCINATION SITE PAIN (Whole body started to ache) and HEADACHE (Bad headache). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (Arm started to ache), PARAESTHESIA ORAL (tongue felt weird), GLOSSODYNIA (tongue was stinging), MYALGIA (achiness), FATIGUE (tiredness), VACCINATION SITE PAIN (Whole body started to ache) and HEADACHE (Bad headache) outcome was unknown.            Multivitamin, Antihistamine, Vitamin D and Calcium used as a Concomitant medication. Treatment medication were not reported/unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia oral, Vaccination site pain
Clinical narrative: flu like symptoms; Arm started to ache; tongue felt weird; tongue was stinging; achiness; tiredness; Whole body started to ache; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (Arm started to ache), PARAESTHESIA ORAL (tongue felt weird), GLOSSODYNIA (tongue was stinging) and MYALGIA (achiness) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] and CALCIUM for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (Arm started to ache), PARAESTHESIA ORAL (tongue felt weird), GLOSSODYNIA (tongue was stinging), MYALGIA (achiness), FATIGUE (tiredness), VACCINATION SITE PAIN (Whole body started to ache) and HEADACHE (Bad headache). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (Arm started to ache), PARAESTHESIA ORAL (tongue felt weird), GLOSSODYNIA (tongue was stinging), MYALGIA (achiness), FATIGUE (tiredness), VACCINATION SITE PAIN (Whole body started to ache) and HEADACHE (Bad headache) outcome was unknown.            Multivitamin, Antihistamine, Vitamin D and Calcium used as a Concomitant medication. Treatment medication were not reported/unknown.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: It weighed me down a little; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (It weighed me down a little) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced FATIGUE (It weighed me down a little). On 30-Mar-2021, FATIGUE (It weighed me down a little) had resolved. Not Provided          Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-083276 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083276:Wife case
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: flu-ish; feverish; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-ish) and PYREXIA (feverish) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-ish) and PYREXIA (feverish). At the time of the report, INFLUENZA LIKE ILLNESS (flu-ish) and PYREXIA (feverish) outcome was unknown.            No concomitant medication and treatment information was provided.  Action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Peripheral swelling
Clinical narrative: arm was swollen/arm was swollen; slept for 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm was swollen/arm was swollen) and HYPERSOMNIA (slept for 4 days) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Sinus infection.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced PERIPHERAL SWELLING (arm was swollen/arm was swollen) and HYPERSOMNIA (slept for 4 days). At the time of the report, PERIPHERAL SWELLING (arm was swollen/arm was swollen) and HYPERSOMNIA (slept for 4 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to -MODERNATX, INC.-MOD-2021-083147 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-083147:CROSSLINKED WITH DOSE 2
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: lung issues from COVID came back; cough with phlegm; can't speak properly because she loses her breath; muscle aches; very fatigued; chills/ teeth were chattering; fever; headache/ tremondous headache; muscle cramping; couldn't sleep; stomach started to sear; This spontaneous case was reported by a consumer and describes the occurrence of LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), ABDOMINAL DISCOMFORT (stomach started to sear), DYSPNOEA (can't speak properly because she loses her breath) and MUSCLE SPASMS (muscle cramping) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache). On 16-Apr-2021, the patient experienced LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath), MYALGIA (muscle aches) and FATIGUE (very fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Apr-2021, ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), MYALGIA (muscle aches), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache) had resolved. At the time of the report, LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath) and FATIGUE (very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Lung disorder, Muscle spasms, Myalgia, Productive cough
Clinical narrative: lung issues from COVID came back; cough with phlegm; can't speak properly because she loses her breath; muscle aches; very fatigued; chills/ teeth were chattering; fever; headache/ tremondous headache; muscle cramping; couldn't sleep; stomach started to sear; This spontaneous case was reported by a consumer and describes the occurrence of LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), ABDOMINAL DISCOMFORT (stomach started to sear), DYSPNOEA (can't speak properly because she loses her breath) and MUSCLE SPASMS (muscle cramping) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache). On 16-Apr-2021, the patient experienced LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath), MYALGIA (muscle aches) and FATIGUE (very fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Apr-2021, ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), MYALGIA (muscle aches), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache) had resolved. At the time of the report, LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath) and FATIGUE (very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: lung issues from COVID came back; cough with phlegm; can't speak properly because she loses her breath; muscle aches; very fatigued; chills/ teeth were chattering; fever; headache/ tremondous headache; muscle cramping; couldn't sleep; stomach started to sear; This spontaneous case was reported by a consumer and describes the occurrence of LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), ABDOMINAL DISCOMFORT (stomach started to sear), DYSPNOEA (can't speak properly because she loses her breath) and MUSCLE SPASMS (muscle cramping) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache). On 16-Apr-2021, the patient experienced LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath), MYALGIA (muscle aches) and FATIGUE (very fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Apr-2021, ABDOMINAL DISCOMFORT (stomach started to sear), MUSCLE SPASMS (muscle cramping), INSOMNIA (couldn't sleep), MYALGIA (muscle aches), CHILLS (chills/ teeth were chattering), PYREXIA (fever) and HEADACHE (headache/ tremondous headache) had resolved. At the time of the report, LUNG DISORDER (lung issues from COVID came back), PRODUCTIVE COUGH (cough with phlegm), DYSPNOEA (can't speak properly because she loses her breath) and FATIGUE (very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Itchy; Warm to touch; Small red circle on upper left arm at injection site; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch), INJECTION SITE ERYTHEMA (Small red circle on upper left arm at injection site), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PRURITUS (Itchy) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B12A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch), INJECTION SITE ERYTHEMA (Small red circle on upper left arm at injection site) and VACCINATION SITE SWELLING (Swollen). On 19-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy). On 14-Apr-2021, INJECTION SITE ERYTHEMA (Small red circle on upper left arm at injection site) and VACCINATION SITE SWELLING (Swollen) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm to touch) and VACCINATION SITE PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Vaccination site erythema, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PAIN (Injection site tender to the touch) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced MALAISE (Feeling sick), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PAIN (Injection site tender to the touch). At the time of the report, MALAISE (Feeling sick), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PAIN (Injection site tender to the touch) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were provided by reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant included inhalers for COPD  Treatment information was not provided.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported daily vitamin, and declined to list states she is on many medications   This case was linked to MOD-2021-083151 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Feeling abnormal, Headache, Hyperhidrosis, Lymph node pain
Clinical narrative: large bruise on right breast; swollen lymph nodes under right arm; tenderness in her lymph nodes; Feels like she has been put through the ringer; sensitivity under right arm; Almost passed out; Dry-heaves; Became sweaty; Headaches; Nausea; 102 Fever; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Almost passed out), RETCHING (Dry-heaves), HYPERHIDROSIS (Became sweaty), FEELING ABNORMAL (Feels like she has been put through the ringer) and SENSITIVE SKIN (sensitivity under right arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypothyroidism, High cholesterol and Contrast media allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ROSUVASTATIN CALCIUM (CRESTOR), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and ZINC for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PRESYNCOPE (Almost passed out) and HYPERHIDROSIS (Became sweaty). 20-Apr-2021, the patient experienced RETCHING (Dry-heaves), SENSITIVE SKIN (sensitivity under right arm), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (102 Fever). On 21-Apr-2021, the patient experienced FEELING ABNORMAL (Feels like she has been put through the ringer). On 22-Apr-2021, the patient experienced CONTUSION (large bruise on right breast) and LYMPHADENOPATHY (swollen lymph nodes under right arm). 22-Apr-2021, the patient experienced LYMPH NODE PAIN (tenderness in her lymph nodes). On 22-Apr-2021, PRESYNCOPE (Almost passed out), RETCHING (Dry-heaves), HYPERHIDROSIS (Became sweaty), SENSITIVE SKIN (sensitivity under right arm), NAUSEA (Nausea) and PYREXIA (102 Fever) had resolved. At the time of the report, FEELING ABNORMAL (Feels like she has been put through the ringer), CONTUSION (large bruise on right breast), LYMPHADENOPATHY (swollen lymph nodes under right arm), LYMPH NODE PAIN (tenderness in her lymph nodes) and HEADACHE (Headaches) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Ultrasound breast: Negative.         .   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: Significant Follow-up appended.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nausea, Presyncope, Pyrexia, Retching
Clinical narrative: large bruise on right breast; swollen lymph nodes under right arm; tenderness in her lymph nodes; Feels like she has been put through the ringer; sensitivity under right arm; Almost passed out; Dry-heaves; Became sweaty; Headaches; Nausea; 102 Fever; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Almost passed out), RETCHING (Dry-heaves), HYPERHIDROSIS (Became sweaty), FEELING ABNORMAL (Feels like she has been put through the ringer) and SENSITIVE SKIN (sensitivity under right arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypothyroidism, High cholesterol and Contrast media allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ROSUVASTATIN CALCIUM (CRESTOR), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and ZINC for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PRESYNCOPE (Almost passed out) and HYPERHIDROSIS (Became sweaty). 20-Apr-2021, the patient experienced RETCHING (Dry-heaves), SENSITIVE SKIN (sensitivity under right arm), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (102 Fever). On 21-Apr-2021, the patient experienced FEELING ABNORMAL (Feels like she has been put through the ringer). On 22-Apr-2021, the patient experienced CONTUSION (large bruise on right breast) and LYMPHADENOPATHY (swollen lymph nodes under right arm). 22-Apr-2021, the patient experienced LYMPH NODE PAIN (tenderness in her lymph nodes). On 22-Apr-2021, PRESYNCOPE (Almost passed out), RETCHING (Dry-heaves), HYPERHIDROSIS (Became sweaty), SENSITIVE SKIN (sensitivity under right arm), NAUSEA (Nausea) and PYREXIA (102 Fever) had resolved. At the time of the report, FEELING ABNORMAL (Feels like she has been put through the ringer), CONTUSION (large bruise on right breast), LYMPHADENOPATHY (swollen lymph nodes under right arm), LYMPH NODE PAIN (tenderness in her lymph nodes) and HEADACHE (Headaches) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Ultrasound breast: Negative.         .   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: Significant Follow-up appended.